Aytu BioPharma, Inc. ( AYTU) Q2 2026 Earnings Call February 3, 2026 4:30 PM EST Good day, everyone, and welcome to the Aytu ...
BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.
The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?
一些您可能无法访问的结果已被隐去。
显示无法访问的结果